Dr. Klingensmith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1775 Aurora Ct
Aurora, CO 80045Phone+1 720-724-2323- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Pediatric Endocrinology, 1974 - 1976
- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1972 - 1974
- University of Colorado School of MedicineInternship, Transitional Year, 1971 - 1972
- Duke University School of MedicineClass of 1971
Certifications & Licensure
- CO State Medical License Active through 2019
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- In-Clinic and Home-Use Study of a New Blood Glucose Monitoring System Start of enrollment: 2008 Dec 01
- Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults Start of enrollment: 2013 Nov 01
- Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- 9 citationsEfficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO...Lori M Laffel, Thomas Danne, Georgeanna J Klingensmith, William V Tamborlane, Steven Willi, Philip Zeitler, Dietmar Neubacher, Jan Marquard> ;The Lancet. Diabetes & Endocrinology. 2023 Mar 1
- 1 citationsZnT8 autoantibody prevalence is low in youth with type 2 diabetes and associated with higher insulin sensitivity, lower insulin secretion, and lower disposition index.Janine Higgins, Philip Zeitler, Kimberly L Drews, Silva Arslanian, Kenneth Copeland, Robin Goland, Georgeanna Klingensmith, Terri H Lipman, Sherida Tollefsen> ;Journal of Clinical & Translational Endocrinology. 2022 Sep 1
- 2 citationsYouth with type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: A Pediatric Diabetes Consortium study.Risa M Wolf, Peiyao Cheng, Robin L Gal, Lindsey C Beaulieu, Craig Kollman, Elvira Isganaitis, Sheela Magge, Lucy D Mastrandrea, Georgeanna J Klingensmith, William Tamb...> ;Pediatric Diabetes. 2022 Jun 1
- Join now to see all
Press Mentions
- Youth with Type 1 Diabetes May Suffer Health Risks When Transitioning from Pediatric to Adult CareFebruary 10th, 2016
Grant Support
- Gonadotrophin Releasing Hormone Antagonist/Treatment Isosexual PrecocityNational Center For Research Resources1987–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: